M&A Deal Summary

Investcorp Acquires Lu Daopei Medical

On September 14, 2020, asset manager Investcorp acquired life science company Lu Daopei Medical

Acquisition Highlights
  • This is Investcorp’s 2nd transaction in the Life Science sector.
  • This is Investcorp’s 3rd transaction in China.

M&A Deal Summary

Date 2020-09-14
Target Lu Daopei Medical
Sector Life Science
Buyer(s) Investcorp
Deal Type Buyout (LBO, MBO, MBI)

Target

Lu Daopei Medical

Beijing, China
Lu Daopei Medical Group is a private specialist medical group in the field of hematology in China and a pioneer in bone marrow transplants. Lu Daopei operates three hospitals in Beijing and a fourth one set to open in Shanghai and is now the largest bone marrow transplant group for leukemia treatment in the world. Lu Daopei Medical was founded in 2001 and is based in Beijing, China.

Search 206,010 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Investcorp

New York, New York, United States

Investor Investor Investor Investor


Category Asset Manager
Founded 1982
PE ASSETS 53.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Investcorp is a global investment group focused on a variety of investment disciplines. Practice areas include private equity in North America and Western Europe, hedge funds, US real estate, technology investments, and Middle Eastern private equity. Within North America/Europe private equity, Investcorp targets market leaders with proven track records. It looks to invest $15 to $50 million in companies with revenues of $10 to $250 million. Investcorp's technology group sponsors growth-oriented control investments in the tech sector. Investcorp's Middle East practice focuses on buyout/build opportunities in North Africa and the Gulf Region. Target sectors include services, infrastructure, manufacturing, and energy. Investcorp was formed in 1982 and is based in Manama, Bahrain.


DEAL STATS #
Overall 154 of 187
Sector: Life Science M&A 2 of 4
Type: Buyout (LBO, MBO, MBI) M&A Deals 47 of 61
Country: China M&A 3 of 6
Year: 2020 M&A 5 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-14 WeDoctor

Hangzhou, China

WeDoctor is an online healthcare services company. The company has more than 240 million registered users for its online doctors consultation, prescription and diagnosis services. The company builds, owns and operates digital healthcare infrastructure platforms by linking hospitals and doctors with patients, pharmacies, insurance programs and financial services. WeDoctor was founded in 2010 and is based in Hangzhou, China.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-27 Freshtohome

Bangalore, India

FreshToHome is a direct-to-consumer online meat brands in India, focused on providing a wide variety of fresh and hygienic seafood and meat at the convenience of doorstep delivery to the consumer. It manages the entire supply chain for seafood and meat from direct procurement from fishermen to last mile delivery through its innovative technology platform. Freshtohome was founded in 2015 and is based in Bangalore, Karnataka.

Buy -